Amplification of the UQCRFS1 Gene in Gastric Cancers

Overview

Journal J Gastric Cancer

Date 2012 Jul 14

PMID 22792519

Citations 9

Authors

Kyong Hwa Jun

Su Young Kim

Jung Hwan Yoon

Jae Hwi Song

Won Sang Park

Affiliations

Soon will be listed here.

Abstract

Purpose: The specific aim of this study is to unravel a DNA copy number alterations, and to search for novel genes that are associated with the development of Korean gastric cancer.

Materials And Methods: We investigated a DNA copy number changes in 23 gastric adenocarcinomas by array-comparative genomic hybridization and quantitative real-time polymerase chain reaction analyses. Besides, the expression of UQCRFS1, which shows amplification in array-CGH, was examined in 186 gastric cancer tissues by an immunohistochemistry, and in 9 gastric cancer cell lines, as well as 24 gastric cancer tissues by immunoblotting.

Results: We found common gains at 48 different loci, and a common loss at 19 different loci. Amplification of UQCRFS1 gene at 19q12 was found in 5 (21.7%) of the 23 gastric cancers in an array-comparative genomic hybridization and DNA copy number were increased in 5 (20.0%) out of the 25 gastric cancer in quantitative real-time polymerase chain reaction. In immunohistochemistry, the overexpression of the protein was detected in 105 (56.5%) out of the 186 gastric cancer tissues. Statistically, there was no significant relationship between the overexpression of UQCRFS1 and clinicopathologic parameters (P>0.05). In parallel, the overexpression of UQCRFS1 protein was confirmed in 6 (66.7%) of the 9 gastric cancer cell lines, and 12 (50.0%) of the 24 gastric cancer tissues by immunoblotting.

Conclusions: These results suggest that the overexpression of UQCRFS1 gene may contribute to the development and/or progression of gastric cancer, and further supported that mitochondrial change may serve as a potential cancer biomarker.

Citing Articles

UQCRFS1 serves as a prognostic biomarker and promotes the progression of ovarian cancer.

Sun Q, Li J, Dong H, Zhan J, Xiong X, Ding J Sci Rep. 2023; 13(1):8335.

PMID: 37221238 PMC: 10205806. DOI: 10.1038/s41598-023-35572-z.

-Regulated Transcriptome and Its Therapeutic Significance in Ovarian Cancer.

Ha J, Jayaraman M, Yan M, Dhanasekaran P, Isidoro C, Song Y Biomolecules. 2021; 11(8).

PMID: 34439877 PMC: 8393559. DOI: 10.3390/biom11081211.

Development of a Four-mRNA Expression-Based Prognostic Signature for Cutaneous Melanoma.

Bai H, Wang Y, Liu H, Lu J Front Genet. 2021; 12:680617.

PMID: 34335689 PMC: 8320537. DOI: 10.3389/fgene.2021.680617.

Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients.

Cavalloni G, Peraldo-Neia C, Massa A, Bergamini C, Trentini A, De Rosa G BMC Cancer. 2021; 21(1):865.

PMID: 34320944 PMC: 8317365. DOI: 10.1186/s12885-021-08576-z.

Dual Regulatory Mechanisms of Expression and Mutation Involving Metabolism-Related Genes FDFT1 and UQCR5 during CLM.

Ma Y, Wu Z, Zhang H, Cai B, Huang T, Long H Mol Ther Oncolytics. 2019; 14:172-178.

PMID: 31236441 PMC: 6579909. DOI: 10.1016/j.omto.2019.04.008.

References

Sugihara H, Hattori T, Fujita S, Hirose K, Fukuda M . Regional ploidy variations in signet ring cell carcinomas of the stomach. Cancer. 1990; 65(1):122-9. DOI: 10.1002/1097-0142(19900101)65:1<122::aid-cncr2820650125>3.0.co;2-q. View

Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S . Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998; 4(7):844-7. DOI: 10.1038/nm0798-844. View

Wolf M, Mousses S, Hautaniemi S, Karhu R, Huusko P, Allinen M . High-resolution analysis of gene copy number alterations in human prostate cancer using CGH on cDNA microarrays: impact of copy number on gene expression. Neoplasia. 2004; 6(3):240-7. PMC: 1502104. DOI: 10.1593/neo.3439. View

Hattori T, Sugihara H, Fukuda M, Hamada S, Fujita S . DNA ploidy patterns of minute carcinomas in the stomach. Jpn J Cancer Res. 1986; 77(3):276-81. View

Yoon J, Song J, Zhang C, Jin M, Kang Y, Nam S . Inactivation of the Gastrokine 1 gene in gastric adenomas and carcinomas. J Pathol. 2011; 223(5):618-25. DOI: 10.1002/path.2838. View

Weiss M, Kuipers E, Postma C, Snijders A, Pinkel D, Meuwissen S . Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival. Cell Oncol. 2004; 26(5-6):307-17. PMC: 4611111. DOI: 10.1155/2004/454238. View

Jung K, Park S, Kong H, Won Y, Lee J, Park E . Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008. Cancer Res Treat. 2011; 43(1):1-11. PMC: 3072529. DOI: 10.4143/crt.2011.43.1.1. View

Bizari L, Borim A, Leite K, Goncalves F, Cury P, Tajara E . Alterations of the CCND1 and HER-2/neu (ERBB2) proteins in esophageal and gastric cancers. Cancer Genet Cytogenet. 2006; 165(1):41-50. DOI: 10.1016/j.cancergencyto.2005.08.031. View

Rossi E, Klersy C, Manca R, Zuffardi O, Solcia E . Correlation between genomic alterations assessed by array comparative genomic hybridization, prognostically informative histologic subtype, stage, and patient survival in gastric cancer. Hum Pathol. 2011; 42(12):1937-45. DOI: 10.1016/j.humpath.2011.02.016. View

10.

Kim H, Park W, Kang S, Warda M, Kim N, Ko J . Mitochondrial alterations in human gastric carcinoma cell line. Am J Physiol Cell Physiol. 2007; 293(2):C761-71. DOI: 10.1152/ajpcell.00043.2007. View

11.

Tsukamoto Y, Uchida T, Karnan S, Noguchi T, Nguyen L, Tanigawa M . Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer. J Pathol. 2008; 216(4):471-82. DOI: 10.1002/path.2424. View

12.

Rieske J . Composition, structure, and function of complex III of the respiratory chain. Biochim Biophys Acta. 1976; 456(2):195-247. DOI: 10.1016/0304-4173(76)90012-4. View

13.

Hyman E, Kauraniemi P, Hautaniemi S, Wolf M, Mousses S, Rozenblum E . Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res. 2002; 62(21):6240-5. View

14.

Ohashi Y, Kaneko S, Cupples T, Robert Young S . Ubiquinol cytochrome c reductase (UQCRFS1) gene amplification in primary breast cancer core biopsy samples. Gynecol Oncol. 2004; 93(1):54-8. DOI: 10.1016/j.ygyno.2004.01.019. View

15.

Fiskum G, Starkov A, Polster B, Chinopoulos C . Mitochondrial mechanisms of neural cell death and neuroprotective interventions in Parkinson's disease. Ann N Y Acad Sci. 2003; 991:111-9. DOI: 10.1111/j.1749-6632.2003.tb07469.x. View

16.

Calcagno D, Leal M, Seabra A, Khayat A, Chen E, Demachki S . Interrelationship between chromosome 8 aneuploidy, C-MYC amplification and increased expression in individuals from northern Brazil with gastric adenocarcinoma. World J Gastroenterol. 2006; 12(38):6207-11. PMC: 4088119. DOI: 10.3748/wjg.v12.i38.6207. View

17.

Kaneko S, Gerasimova T, Smith S, Lloyd K, Suzumori K, Robert Young S . CA125 and UQCRFS1 FISH studies of ovarian carcinoma. Gynecol Oncol. 2003; 90(1):29-36. DOI: 10.1016/s0090-8258(03)00144-6. View

18.

Jarvinen A, Autio R, Haapa-Paananen S, Wolf M, Saarela M, Grenman R . Identification of target genes in laryngeal squamous cell carcinoma by high-resolution copy number and gene expression microarray analyses. Oncogene. 2006; 25(52):6997-7008. DOI: 10.1038/sj.onc.1209690. View

19.

Rozen S, Skaletsky H . Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol. 1999; 132:365-86. DOI: 10.1385/1-59259-192-2:365. View

20.

Buffart T, Carvalho B, Hopmans E, Brehm V, Kranenbarg E, Schaaij-Visser T . Gastric cancers in young and elderly patients show different genomic profiles. J Pathol. 2006; 211(1):45-51. DOI: 10.1002/path.2085. View